Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind Trial of MP29-02 Nasal Spray Compared to Placebo, Astelin Nasal Spray, and Fluticasone Propionate Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis

NCT00660517 is registered in ClinicalTrials.gov with Meda Pharmaceuticals as lead sponsor.

NCT NCT00660517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00660517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind Trial of MP29-02 Nasal Spray Compared to Placebo, Astelin Nasal Spray, and Fluticasone Propionate Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis
Lead sponsor
Meda Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2007
Completion date
April 30, 2008
Enrollment
607 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

seasonal allergic rhinitis